CRISPR Tackles Diverse Single-Gene Conditions
PLOS: DNA Science
JANUARY 4, 2024
The end-of-year FDA approval of the first CRISPR-based therapy , for sickle cell disease, came a mere dozen years after Jennifer Doudna and Emmanuelle Charpentier introduced the technology. They shared the Nobel Prize in Chemistry in 2020. CRISPR is one of the better abbreviations in genetics. It restores vision in just days.
Let's personalize your content